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SUMMARY
Keloids are benign hyperproliferative growths of
dermal fibroblasts characterized by excessive, and
often times extensive, deposition of extracellular
matrix components especially collagen and
fibronectin.  First described in the Edward Smith
papyrus in Egypt around 1700 BC, the
aetiopathogenesis of the disease has become one
of  the greatest enigmas in modern medicine.
Studies have shown that the condition is
significantly more common in the coloured races,
especially those of African origin. This brief
exposition focuses on an exciting and potentially
revolutionary study of  this condition by the
University College Hopital, Ibadan, team of
plastic surgeons led by Professor Oluwatosin and
collaborators from the University of Connecticut,
USA. The team hopes to uncover the genetic basis
of African keloids that may lead to the
development of more effective diagnostic,
therapeutic and prognostic interventions.
Perhaps the most fundamental process of primary
interest to surgeons is wound healing. Wound healing
involves a well-orchestrated sequence of  events. The
history of wound care is both ancient and modern.
The treatment of acute and chronic wounds can be
traced as far back as ancient Egypt and Greece. Galen
of  Pergamun, a Greek surgeon who served Roman
gladiators circa 120–201 AD 1, made many
contributions to the field of wound care. In more
recent times (1860 onwards) notable names include
Ignaz Phillipp Semmelweis, Joseph Lister, Paul
Leopold Freidrich (who introduced wound excision),
Theodor Billroth, Theodor Kocher and others. These
heroes of surgery made major advances to wound
care and wound healing.
With the advent of modern scientific techniques, the
practice of surgery has become founded on well
researched scientific principles. Advances in cell biology
have showed that wound healing is a complex event
involving cellular, host, psychological, and
environmental factors. The process of  wound healing
can be divided into inflammatory, proliferative, and
maturation phases2. These phases are associated with
very complex cascades of signaling molecules and
growth factors. Studies have continued to improve
the outcomes of surgically inflicted wounds, however,
in a small percentage of individuals the proliferative
phase takes an abnormal course resulting in excessive
formation of  scar tissue. Such non-malignant,
abnormal outcomes of  cutaneous wound healing, are
referred to as hypertrophic scars and keloids.
Keloids are defined as scars within the skin that grow
beyond the confines of the original wound. This
process may be delayed for months, rarely years after
the initial injury before starting but once keloids are
formed, they do not regress spontaneously. In contrast,
hypertrophic scars are raised lesions that stay within
the boundaries of the wound. They usually appear
within weeks of the causative injury and tend to regress
spontaneously over time3. The first description of
abnormal scar formation in the form of  keloids was
recorded in the Smith papyrus regarding surgical
techniques in Egypt around 1700 BC. The term keloids
meaning ‘crab claw’ was coined by Jean Louis Albert
in 1806 3. Since that time the condition has gained the
reputation of being one of the greatest enigmas in
modern medicine.
The specific aetiopathogenesis of keloids is unknown4.
However, the process is known to be induced by skin
trauma in predisposed individuals. In addition, the
condition has been observed in only humans and they
CHRONICLES OF MEDICAL HISTORY
THE SEARCH FOR THE GENETIC BASIS OF AFRICAN KELOIDS
O.S. Michael




                                                   Annals of Ibadan Postgraduate Medicine. Vol. 10 No. 2 December, 2012 53
Ann Ibd. Pg. Med 2012. Vol.10, No.2 53-55
occur at any age. Studies have also shown that females
may be more at risk of developing keloids, and
interestingly, that the incidence of  keloids in albinos is
extremely low; they have been shown to be consistently
more common in colored races especially Africans5.
The reason for this racial difference is not known.
Rapid advances in molecular techniques have made it
possible to identify molecular correlates of clinical
characteristics of the disease. Findings indicate a varied
inheritance pattern in keloids disease (predominantly
autosomal dominant), linkage loci (chromosomes 2q23
and 7p11), several human leukocyte antigen (HLA)
alleles (HLA-DRB1*15, HLA-DQA1*0104, DQ-
B1*0501 and DQB1*0503), negative candidate gene
case–control association studies and at least 25
deregulated genes reported in multiple microarray
studies6. In summary, involvement of  more than one
gene is likely to be responsible for susceptibility to
keloids disease. As keloid is a benign tumor, the
possibility that the genetic basis of the disease is closely
related to that of malignancies of similar tissues is of
considerable significance.
The global trend has shifted from clinical research to
the identification of molecular basis of diseases in the
search for effective cures. Keloids disease is being
researched by many international groups. Here at the
University College Hospital (UCH), the department
of plastic surgery has been carrying out cutting edge
research on keloids. This unique project started 5 yrs
ago and involves UCH, Ladoke Akintola University
of  Technology (LAUTECH), and international
collaborators from the University of Connecticut. This
project, an individual collaborative effort, has received
funding on a yearly basis that has led to high quality
sample, data collection, and analyses.
is carried out. Using cutting edge molecular techniques,
specific DNA regions are amplified and sequenced.
Gene associations studies are carried out to identify
genetic polymorphisms linked with African keloids.
Early results have identified molecular markers (SNPs)
with significant linkages with clinical characteristics of
keloids in the population studied. Some alleles that
seem to increase the risk of keloids development in
the mostly yoruba population have also been identified7.
The research, however, is still ongoing and the results
of the main objectives of the project are being
determined.
The therapeutic implications of this keloids project
are obvious. To date, the treatment of  keloids remains
a challenge. This is because the exact aetiopathogenesis
of the disease has continued to elude researchers4.
Molecular studies hold the potential of identifying
exact biochemical pathways involved in disease and
providing specific targets for effective therapies.
Surgical excision followed by intra-lesional steroid
injection seems to be the treatment option with the
lowest recurrence rate, while radiotherapy is reserved
for those who fail this treatment8. This is the current
practice. However, using tissue culture techniques, the
keloids group recently reported that oils rich in omega-
3 fatty acids may be more effective and affordable
than surgical excisions and intralesional steroids as a
treatment option. The group was able to demonstrate
rapid inhibition of actively proliferating keloids
fibroblasts9. The role of vitamin D in the inhibition
of keloid fibroblasts (KFs) 10 may not be unconnected
to effects of  omega-3 on KFs reported by the group.
This early report is a pointer to the significance of this
African study.
No endeavor is free of  challenges. While the group
has made progress within the set time frame, challenges
have not been infrequent. Limited resources for
molecular analysis led to heavy reliance on the
international collaborators for the molecular aspects
of the project. Frequent power outages resulted in the
group’s search for more robust storage facility and
prompt shipping of  samples. With a target of  enrolling
20 patients/month, there were a few months where
the expected number was difficult to attain. However,
funding has been regular and the study has been a
success, and continues to achieve set targets.
This is the first study to characterize the genetic basis
of  keloids in sub-saharan African patients. The keloids
study group has shown that with good collaboration,
focus, hard work, excellent leadership, and team work,
cutting edge research is possible in our local setting.
Perhaps there is no other region in the world where
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The team hopes to identify unique genetic associations
in Africans with keloids disease. The research involves
the collection of blood, saliva, and tissue samples from
patients with keloids, regardless of other co-
morbidities. Samples are ethically obtained from cases
and controls (patients with normal scar tissue
responses). These samples collected in Nigeria are
processed and transported abroad where further work
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disease occurs in its most natural form than Africa,
this is the major advantage that the Ibadan-Connecticut
keloids research group has over other keloids research
groups. This advantage is also available for the study
of other diseases prevalent in our sub-region. Great
adventures in medical history are always similar to the
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